1-2 of 2
Taro Semba
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Dose Escalation Data from the Phase 1 Study of the Liposomal Formulation of Eribulin (E7389-LF) in Japanese Patients with Advanced Solid Tumors

Jun Sato, Toshio Shimizu, Takafumi Koyama, Satoru Iwasa, Akihiko Shimomura, Shunsuke Kondo, Shigehisa Kitano, Kan Yonemori, Yutaka Fujiwara, Kenji Tamura, Takuya Suzuki, Takao Takase, Reiko Nagai, Kohei Yamaguchi, Taro Semba, Zi-Ming Zhao, Min Ren, Noboru Yamamoto
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (9): 1783–1791.
DOI: https://doi.org/10.1158/1078-0432.CCR-21-3518
Published: 02 May 2022
View article
PDF
Includes: Supplementary data
Journal Articles

An Angiogenesis Inhibitor E7820 Shows Broad-Spectrum Tumor Growth Inhibition in a Xenograft Model: Possible Value of Integrin α2 on Platelets as a Biological Marker

Taro Semba, Yasuhiro Funahashi, Naoto Ono, Yuji Yamamoto, Naoko Hata Sugi, Makoto Asada, Kentaro Yoshimatsu, Toshiaki Wakabayashi
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (4): 1430–1438.
DOI: https://doi.org/10.1158/1078-0432.CCR-0109-03
Published: 20 February 2004
View article
PDF